Pharma Strategy Blog

This weekend I’m at the annual meeting of the European Association of Urology (EAU), which takes place here in Vienna, Austria.  It promises to be an interesting meeting, with new developments in the areas of bladder/urothelial, prostate and renal cancers being discussed.

For those of you interested in following remotely, here are the links to the scientific programme and the podcasts.  You can also browse the abstracts online.

According to the EAU:

“For the 2011 edition, more than 3,700 abstracts were submitted and reviewed by the EAU Scientific Congress Office. As a result, 1,111 abstracts and 50 video abstracts were accepted, and will be presented at 92 poster sessions and 8 video sessions.”

While not as big as it’s American cousin, the AUA, that’s still an impressive number of abstracts submitted for the meeting.  They have an active presence on Twitter, you follow them via @uroweb.

I’m going to try and aggregate my thoughts and tweets from the sessions, depending upon the availability of wifi access.  Most of the sessions I’m interested in will be from Saturday to Monday.  Unfortunately, my iPad didn’t arrive in time so the iPhone and wifi will sadly have to suffice, although coverage may be spotty with thousands of people also trying to access the network.

Check back over the weekend for any live tweeting for the hashtag #EAU11 (#EAU is unfortunately used for other things, including water tweets), but you can follow the #EAU11 coverage in the widget below:

If any one has any questions or observations, please do add them in the comments below.